logo

Imv Inc. (IMV)



Trade IMV now with
  Date
  Headline
5/13/2022 7:17:21 AM IMV Q1 Loss Per Share $0.13 Vs Loss $0.10 Last Year
4/22/2022 7:08:04 AM IMV Inc. Names Michael Bailey Chairman Of Board
1/12/2022 7:09:39 AM IMV Doses First Patient In VITALIZE Phase 2B Clinical Study Evaluating MVP-S With KEYTRUDA In Patients With R/r DLBCL
12/22/2021 7:07:06 AM IMV Appoints Andrew Hall As CEO, Effective Jan 1
11/30/2021 7:12:31 AM IMV Says First Patient Dosed In Phase 1b Clinical Study Evaluating Its Lead Compound In Patients With Breast Cancer
11/22/2021 8:07:41 AM IMV CFO Pierre Labb To Retire On March 31, 2022
8/10/2021 7:59:07 AM IMV Announces Final Topline Results Of DeCidE1 Clinical Trial In Advanced Recurrent Ovarian Cancer
8/4/2021 8:33:42 AM IMV: Frederic Ors Steps Down As CEO
7/15/2021 7:07:40 AM IMV Prices Public Offering Of 14.3 Mln Units At $1.75/unit
5/12/2021 7:09:27 AM IMV Inc. Q1 Net Loss $7.0 Mln Vs. Net Loss $7.2 Mln Last Year